Cargando…
Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
Cisplatin resistance in testicular germ cell tumors (TGCTs) is a clinical challenge. We investigated the underlying mechanisms associated with cancer stem cell (CSC) markers and modalities circumventing the chemoresistance. Chemoresistant models (designated as CisR) of human embryonal carcinoma cell...
Autores principales: | Schmidtova, Silvia, Kalavska, Katarina, Gercakova, Katarina, Cierna, Zuzana, Miklikova, Svetlana, Smolkova, Bozena, Buocikova, Verona, Miskovska, Viera, Durinikova, Erika, Burikova, Monika, Chovanec, Michal, Matuskova, Miroslava, Mego, Michal, Kucerova, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769487/ https://www.ncbi.nlm.nih.gov/pubmed/31443351 http://dx.doi.org/10.3390/cancers11091224 |
Ejemplares similares
-
Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
por: Schmidtova, Silvia, et al.
Publicado: (2020) -
Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines
por: Schmidtova, Silvia, et al.
Publicado: (2021) -
Effect of the PARP inhibitor veliparib on germ cell tumor cell lines
por: Schmidtova, Silvia, et al.
Publicado: (2022) -
Prognostic Value of Apoptosis-Inducing Factor (AIF) in Germ Cell Tumors
por: Letkovska, Katarina, et al.
Publicado: (2021) -
Overcoming Chemotherapy Resistance in Germ Cell Tumors
por: Országhová, Zuzana, et al.
Publicado: (2022)